Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
estimates lowered at Goldman through 2012. Company seeing a higher season decline in demand. Buy rating an $39 price target.
price target cut at Barclays by a dollar to $4 as CEO Waller resigns, but challenges remain. Maintain Equal Weight rating.
price target higher at Citi to $41 from $39. Expecting solid 3Q10 results with strong same-store sales, Citigroup said. Maintain Buy rating.
estimates increased at Morgan Stanley through 2012. Company re-financed its debt at lower interest rates. Overweight rating and $39 price target.
price target lifted at Barclays to $34 from $32. Company remains well positioned to gain share with short lead times and crisp execution, Barclays said. Reiterate Overweight rating.
target lowered at UBS to $20. Company likely to receive a lower multiple. Neutral rating.
cut from Conviction Buy List at Goldman. Company lacks near-term catalysts. New $22 price target.
target boosted at Morgan Stanley to $40. Company continues to grow and could even increase its dividend. Overweight rating.
target raised at Goldman to $43. Company had an upbeat investor meeting and should meet its near-term targets.
price target raised at Credit Suisse to $47 from $45 on improved Medicare outlook. Long-term growth estimate raised to 10% from 8%. Maintain Outperform rating.
Universal Technical Institute
price target trimmed at Barclays by a dollar to $17 on disappointing 4Q10 and 2011 outlook, Barclays said. 2011 EPS estimates reduced to $1.34 from $1.48. Maintain Underweight rating.
price target higher at Barclays to $46 from $42. Vale is the top pick in the sector because it's the best positioned to benefit from the iron ore super cycle, Barclays said. Maintain Overweight rating.
This article was written by a staff member of TheStreet.